Chimerix, Inc. (CMRX) DCF Valuation

Chimerix, Inc. (CMRX) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Chimerix, Inc. (CMRX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Chimerix, Inc.'s (CMRX) financial outlook like an expert! This (CMRX) DCF Calculator features pre-filled financials and offers full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 12.5 5.4 2.0 33.8 .3 .2 .2 .1 .1 .1
Revenue Growth, % 0 -57.09 -63.16 1609.15 -99.04 -29.82 -29.82 -29.82 -29.82 -29.82
EBITDA -44.7 -44.1 -90.3 -60.4 -93.0 -.2 -.2 -.1 -.1 -.1
EBITDA, % -356.8 -821.18 -4565.08 -178.53 -28695.68 -100 -100 -100 -100 -100
Depreciation .5 .4 .5 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 3.9 7.22 23.65 0.31634 28.09 12.63 12.63 12.63 12.63 12.63
EBIT -45.2 -44.5 -90.8 -60.5 -93.1 -.2 -.2 -.1 -.1 -.1
EBIT, % -360.7 -828.41 -4588.73 -178.85 -28723.77 -100 -100 -100 -100 -100
Total Cash 113.5 79.0 88.4 217.3 182.8 .2 .2 .1 .1 .1
Total Cash, percent .0 .0 .0 .0 .1 .0 .0 .0 .0 .0
Account Receivables 1.2 .3 .3 1.0 1.1
Account Receivables, % 9.85 6.33 17.58 3.07 351.85
Inventories .0 .0 2.8 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 139.46 0 0 20 20 20 20 20
Accounts Payable 2.4 1.3 2.8 3.0 2.9 .1 .1 .1 .0 .0
Accounts Payable, % 19.15 23.88 140.88 8.97 879.94 50.4 50.4 50.4 50.4 50.4
Capital Expenditure -.2 -.1 -.2 -.1 -.1 .0 .0 .0 .0 .0
Capital Expenditure, % -1.26 -1.08 -10.46 -0.20991 -27.47 -8.1 -8.1 -8.1 -8.1 -8.1
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -69.7 -43.1 -134.1 -60.5 -93.1 -.2 -.2 -.1 -.1 -.1
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -68.2 -43.0 -135.1 -58.1 -93.3 -1.9 -.2 -.1 -.1 -.1
WACC, % 9.75 9.75 9.75 9.75 9.75 9.75 9.75 9.75 9.75 9.75
PV UFCF
SUM PV UFCF -2.0
Long Term Growth Rate, % 0.50
Free cash flow (T + 1) 0
Terminal Value -1
Present Terminal Value 0
Enterprise Value -2
Net Debt -26
Equity Value 24
Diluted Shares Outstanding, MM 89
Equity Value Per Share 0.27

What You Will Gain

  • Pre-Filled Financial Model: Chimerix, Inc.'s (CMRX) actual data provides accurate DCF valuation.
  • Comprehensive Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
  • Real-Time Calculations: Automatic updates allow you to view results instantly as you make adjustments.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
  • Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.

Key Features

  • Comprehensive CMRX Data: Pre-filled with Chimerix’s historical financials and future projections.
  • Fully Customizable Inputs: Modify revenue growth, profit margins, discount rates, tax implications, and capital investments.
  • Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
  • Scenario Testing: Develop various forecast scenarios to evaluate different valuation results.
  • User-Friendly Design: Intuitive, organized, and tailored for both professionals and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Chimerix, Inc. (CMRX) data.
  • Step 2: Navigate through the filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the updated results, including Chimerix, Inc.'s (CMRX) intrinsic value.
  • Step 5: Use the outputs to make informed investment decisions or create detailed reports.

Why Choose This Calculator for Chimerix, Inc. (CMRX)?

  • Designed for Experts: A specialized tool utilized by investors, analysts, and financial advisors.
  • Accurate Data: Chimerix's historical and projected financials preloaded for precision.
  • Flexible Scenario Analysis: Easily simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance to help you navigate the calculator effortlessly.

Who Should Use This Product?

  • Investors: Assess Chimerix, Inc.'s (CMRX) valuation before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and evaluate financial forecasts.
  • Startup Founders: Understand the valuation strategies of established biotech firms like Chimerix, Inc.
  • Consultants: Provide detailed valuation analyses and reports for clients in the healthcare sector.
  • Students and Educators: Utilize current data to learn and teach valuation principles effectively.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Chimerix, Inc. (CMRX) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Chimerix, Inc. (CMRX).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.